P

Inventor

SIFFERLEN THIERRY

CH41 patents
⚠️ This page may combine multiple inventors who share the name “SIFFERLEN THIERRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IDORSIA PHARMACEUTICALS LTD

13 patents
US11241431B2Feb 8, 2022

N-substituted indole derivatives as PGE2 receptor modulators

IDORSIA PHARMACEUTICALS LTD6 citations83
US9732075B2Aug 15, 2017

Benzimidazole-proline derivatives

IDORSIA PHARMACEUTICALS LTD8 citations82
US11325899B2May 10, 2022

Benzofurane and benzothiophene derivatives as PGE2 receptor modulators

IDORSIA PHARMACEUTICALS LTD6 citations73
US10329287B2Jun 25, 2019

Benzimidazole-proline derivatives

IDORSIA PHARMACEUTICALS LTD3 citations72
US10023560B2Jul 17, 2018

Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

IDORSIA PHARMACEUTICALS LTD3 citations72
US9914720B2Mar 13, 2018

Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists

IDORSIA PHARMACEUTICALS LTD3 citations72
US9790208B2Oct 17, 2017

Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

IDORSIA PHARMACEUTICALS LTD4 citations72
US11712438B2Aug 1, 2023

Phenyl derivatives as PGE2 receptor modulators

IDORSIA PHARMACEUTICALS LTD2 citations71
US11446298B2Sep 20, 2022

Pyrimidine derivatives

IDORSIA PHARMACEUTICALS LTD5 citations71
US9914721B2Mar 13, 2018

Use of benzimidazole-proline derivatives

IDORSIA PHARMACEUTICALS LTD4 citations71
US12011444B2Jun 18, 2024

N-substituted indole derivatives as PGE2 receptor modulators

IDORSIA PHARMACEUTICALS LTD2 citations70
US11839613B2Dec 12, 2023

Pyrimidine derivatives as PGE2 receptor modulators

IDORSIA PHARMACEUTICALS LTD1 citations61
US11040966B2Jun 22, 2021

Benzimidazole-proline derivatives

IDORSIA PHARMACEUTICALS LTD0 citations60

ACTELION PHARMACEUTICALS LTD

12 patents
US7994336B2Aug 9, 2011

Azetidine compounds as orexin receptor antagonists

ACTELION PHARMACEUTICALS LTD23 citations92
US8003654B2Aug 23, 2011

N-glycinsulfonamide derivatives and uses as orexin receptor antagonists

ACTELION PHARMACEUTICALS LTD7 citations84
US7834028B2Nov 16, 2010

Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists

ACTELION PHARMACEUTICALS LTD9 citations84
US7435815B2Oct 14, 2008

Sulfonylamino-acetic acid derivatives

ACTELION PHARMACEUTICALS LTD10 citations84
US7279578B2Oct 9, 2007

Sulfonylamino-acetic acid derivatives

ACTELION PHARMACEUTICALS LTD11 citations84
US7192950B2Mar 20, 2007

Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists

ACTELION PHARMACEUTICALS LTD15 citations84
US7538109B2May 26, 2009

Quinoxalin-3-one derivatives as orexin receptor antagonists

ACTELION PHARMACEUTICALS LTD7 citations74
US9493446B2Nov 15, 2016

Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives

ACTELION PHARMACEUTICALS LTD6 citations73
US9211279B2Dec 15, 2015

Proline sulfonamide derivatives as orexin receptor antagonists

ACTELION PHARMACEUTICALS LTD3 citations62
US7915259B2Mar 29, 2011

Diazabicyclononene derivatives and use thereof

ACTELION PHARMACEUTICALS LTD3 citations62
US9403813B2Aug 2, 2016

Azetidine amide derivatives as orexin receptor antagonists

ACTELION PHARMACEUTICALS LTD1 citations52
US7799805B2Sep 21, 2010

Piperidine carboxylic acid amide derivatives

ACTELION PHARMACEUTICALS LTD1 citations51

AISSAOUI HAMED

11 patents

BOLLI MARTIN

2 patents

BOSS CHRISTOPH

2 patents

BEZENCON OLIVIER

1 patent